Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Cultivation Path of Compound Talents in Ophthalmic Diagnosis, Treatment, and Nursing Based on Artificial Intelligence
2
Zitationen
4
Autoren
2022
Jahr
Abstract
Artificial intelligence can effectively improve the efficiency and accuracy of medical diagnosis, clinical data analysis, medical image recognition, treatment plan decision-making, etc. It has broad application prospects in the ophthalmic diagnosis, treatment, and nursing industry. However, the application of artificial intelligence in the ophthalmic diagnosis and nursing industry in China started relatively late, and there are insufficient ophthalmic diagnosis and nursing personnel who are familiar with artificial intelligence technologies. In order to promote the modernization of ophthalmic medicine in China and accelerate the development of a high-quality and modern medical education system, it is necessary to train a new generation of compound ophthalmic medical talents who are skilled in artificial intelligence and develop an advanced talent training model that meets the needs of the ophthalmic profession and the society. Based on the application status and development prospects of artificial intelligence in the ophthalmology industry, this paper analyzes the current medical education model in ophthalmology, examines the path of cultivating compound talents in ophthalmic diagnosis, treatment, and nursing, as well as proposes suggestions for developing a high-quality and modern medical education system.
Ähnliche Arbeiten
Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs
2016 · 7.211 Zit.
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis
2014 · 5.063 Zit.
Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the First International Workshop
2005 · 4.265 Zit.
Global estimates of visual impairment: 2010
2011 · 3.755 Zit.
Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
2006 · 3.472 Zit.